Immediate Impact
2 from Science/Nature 52 standout
Citing Papers
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Lipid nanoparticles for siRNA delivery in cancer treatment
2023 Standout
Works of Harry Cook being referenced
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harry Cook | 259 | 131 | 52 | 194 | 20 | 522 | |
| Paul M. Rosenblum | 316 | 226 | 28 | 203 | 20 | 639 | |
| Yoshihiko Oota | 203 | 112 | 36 | 121 | 15 | 509 | |
| Kei-Li Yu | 195 | 69 | 31 | 265 | 12 | 477 | |
| Giovanni Chieffi | 199 | 66 | 58 | 218 | 36 | 576 | |
| Romain Fontaine | 255 | 119 | 59 | 112 | 50 | 549 | |
| Richard M. Jobin | 273 | 65 | 61 | 279 | 25 | 643 | |
| P Chambolle | 211 | 159 | 109 | 117 | 33 | 495 | |
| Hiroaki Chiba | 274 | 238 | 95 | 117 | 33 | 648 | |
| Somsri Ngamvongchon | 240 | 103 | 17 | 326 | 9 | 498 | |
| Trevor Wigham | 169 | 215 | 138 | 69 | 25 | 524 |
All Works
Loading papers...